Intention-to-treat analysis keeps all trial data, showing true drug effects, even with dropouts. It contrasts with per-protocol analysis, where dropout data is excluded, possibly skewing results.
MedPage Today on MSN
Diabetes drug class tied to lower dementia risk in people with psych disorders
SGLT2 inhibitor use also correlated with lower rates of psychiatric ED visits ...
Median (range) 6.2 (2.3-15.0) 4.5 (2.0-13.7) 4.3 (0.2-14.1) NOTE. Data are No. (%) unless indicated otherwise. The intention-to-treat analysis set included all patients who underwent random assignment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results